Dr. Jonathan Cohen, MD
Claim this profileJadestone Clinical Research, LLC
Studies Coronavirus
Studies COVID-19
19 reported clinical trials
31 drugs studied
Area of expertise
1Coronavirus
SARS-CoV-2
PCR
collection
2COVID-19
SARS-CoV-2
Affiliated Hospitals
Clinical Trials Jonathan Cohen, MD is currently running
Sleep Treatments
for Long COVID Syndrome
The platform protocol is designed to be flexible so that it is suitable for a range of study settings and intervention types. Therefore, the platform protocol provides a general protocol structure that can be shared by multiple interventions and allows comparative analysis across the interventions. For example, objectives, measures, and endpoints are generalized in the platform protocol, but intervention-specific features are detailed in separate appendices. This platform protocol is a prospective, multi-center, multi-arm, randomized controlled platform trial evaluating potential interventions for PASC-mediated sleep disturbances. The hypothesis is that symptoms of sleep and circadian disorders that emerge in patients with PASC can be improved by phenotype-targeted interventions. Specific sleep and circadian disorders addressed in this protocol include sleep-related daytime impairment (referred to as hypersomnia) and complex PASC-related sleep disturbance (reflecting symptoms of insomnia and sleep-wake rhythm disturbance).
Recruiting0 awards Phase 21 criteria
Inhaled Treprostinil
for Pulmonary Fibrosis
Study RIN-PF-305 is designed to evaluate the safety and efficacy of inhaled treprostinil in subjects with progressive pulmonary fibrosis (PPF) over a 52-week period.
Recruiting1 award Phase 311 criteria
More about Jonathan Cohen, MD
Clinical Trial Related1 year of experience running clinical trials · Led 19 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Jonathan Cohen, MD has experience with
- Placebo
- Inhaled Treprostinil
- Montelukast
- Treprostinil Ultrasonic Nebulizer
- TF0023
- Sulindac (HLX-0201)
Breakdown of trials Jonathan Cohen, MD has run
Coronavirus
COVID-19
Idiopathic Pulmonary Fibrosis
Cancer
Interstitial Lung Disease
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jonathan Cohen, MD specialize in?
Jonathan Cohen, MD focuses on Coronavirus and COVID-19. In particular, much of their work with Coronavirus has involved SARS-CoV-2 patients, or patients who are PCR.
Is Jonathan Cohen, MD currently recruiting for clinical trials?
Yes, Jonathan Cohen, MD is currently recruiting for 5 clinical trials in Silver Spring Maryland. If you're interested in participating, you should apply.
Are there any treatments that Jonathan Cohen, MD has studied deeply?
Yes, Jonathan Cohen, MD has studied treatments such as Placebo, Inhaled Treprostinil, Montelukast.
What is the best way to schedule an appointment with Jonathan Cohen, MD?
Apply for one of the trials that Jonathan Cohen, MD is conducting.
What is the office address of Jonathan Cohen, MD?
The office of Jonathan Cohen, MD is located at: Jadestone Clinical Research, LLC, Silver Spring, Maryland 20904 United States. This is the address for their practice at the Jadestone Clinical Research, LLC.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.